
Chronic Lymphocytic Leukemia — An Interview with Prof Constantine Tam on Key Presentations from the 2025 ASH Annual Meeting
Oncology Today with Dr Neil Love
00:00
Double-refractory CLL: frequency and approach
Tam describes double-refractory patients, their typical biology, and options including pirtobrutinib and clinical trials.
Play episode from 37:01
Transcript


